Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Tyrosine kinase inhibitors

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Othman T, et al. Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood 142 (Suppl. 1): 2873, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-187460 [abstract] Othman T, et al. Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood 142 (Suppl. 1): 2873, Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2023-187460 [abstract]
Metadaten
Titel
Tyrosine kinase inhibitors
Various toxicities
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54301-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Nitrofurantoin

Case report

Dalbavancin

Case report

Epinephrine

Case report

Orelabrutinib

Case report

Hydralazine